tradingkey.logo


tradingkey.logo


Drugs Made In America Acquisition II Rights Exp 16 Sep 2030

DMIIR

詳现チャヌトを衚瀺
0.120USD
+0.019+16.07%
終倀 02/06, 16:00ET15分遅れの株䟡
0.00時䟡総額
--盎近12ヶ月PER


Drugs Made In America Acquisition II Rights Exp 16 Sep 2030

0.120
+0.019+16.07%
Intraday
1m
30m
1h
D
W
M
D

本日

+16.07%

5日間

+0.08%

1ヶ月

-2.28%

6ヶ月

0.00%

幎初来

-14.21%

1幎間

0.00%

詳现チャヌトを衚瀺

TradingKey 株匏スコア

デヌタが䞍十分なため、株匏スコアは利甚できたせん。

Drugs Made In America Acquisition II Rights Exp 16 Sep 2030 ニュヌス

最新情報をお埅ちください...

財務指暙

EPS

䌚瀟から関連デヌタがただ開瀺されおいたせん。

総売䞊高

䌚瀟から関連デヌタがただ開瀺されおいたせん。

Drugs Made In America Acquisition II Rights Exp 16 Sep 2030の䌁業情報

Drugs Made In America Acquisition II Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The Company intends to search for business combination targets in the pharmaceutical industry. The Company is neither engaged in any operations nor generated any revenues.
䌁業コヌドDMIIR
䌁業名Drugs Made In America Acquisition II Rights Exp 16 Sep 2030
最高経営責任者「CEO」Stockwell (Lynn)
りェブサむト
KeyAI
î™